UK accuses drugmakers and distributor of non-compete agreements
The UK’s competition enforcer has provisionally found that four companies agreed not to compete in the supply of an anti-nausea tablet to the country’s national health service, resulting in a 700% rise in the price.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.